MARGARET SPITZ to Cells, Cultured
This is a "connection" page, showing publications MARGARET SPITZ has written about Cells, Cultured.
Connection Strength
0.221
-
A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Carcinogenesis. 2007 Jul; 28(7):1430-6.
Score: 0.045
-
Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S26-7.
Score: 0.028
-
Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res. 1998 Apr 15; 58(8):1605-8.
Score: 0.024
-
Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
Score: 0.024
-
Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res. 1996 Sep 01; 56(17):3975-9.
Score: 0.022
-
Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr. 1995; (18):29-33.
Score: 0.019
-
Genetic and environmental interactions as risks for aerodigestive cancers. Adv Exp Med Biol. 1992; 320:31-4.
Score: 0.016
-
Human sensitivity to PhIP: a novel marker for prostate cancer risk. Mutat Res. 2006 Oct 10; 601(1-2):1-10.
Score: 0.011
-
Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer. 2003 Oct; 42(1):1-8.
Score: 0.009
-
In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer. 2001 Aug 01; 93(3):436-40.
Score: 0.008
-
In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res. 1996 Aug 15; 56(16):3638-41.
Score: 0.005
-
Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1996 Jul; 5(7):527-32.
Score: 0.005
-
Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov; 4(7):743-9.
Score: 0.005